Rhythm Pharmaceuticals (RYTM) Insider Trading & Ownership $49.05 -0.56 (-1.13%) (As of 07/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$10.15 M Get RYTM Insider Trade Alerts Want to know when executives and insiders are buying or selling Rhythm Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RYTM Insider Buying and Selling by Quarter Ad Behind the MarketsJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."Click here to see why Wall Street is in PANIC mode >>> Rhythm Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/16/2024Joseph ShulmanInsiderSell10,468$53.00$554,804.00 7/12/2024Joseph ShulmanInsiderSell5,313$50.01$265,703.13 5/9/2024Joseph ShulmanInsiderSell3,984$38.47$153,264.48 4/2/2024Christopher Paul GermanCAOSell368$41.76$15,367.68 3/21/2024Joseph ShulmanInsiderSell18,235$40.34$735,599.90 3/19/2024David P MeekerCEOSell45,494$39.22$1,784,274.68 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/19/2024Hunter C SmithCFOSell15,515$39.22$608,498.30 3/19/2024Yann MazabraudEVPSell16,000$39.22$627,520.00 2/14/2024Joseph ShulmanInsiderSell1,089$50.01$54,460.89 2/12/2024Hunter C SmithCFOSell1,209$51.38$62,118.42 2/12/2024Joseph ShulmanInsiderSell791$51.38$40,641.58 2/12/2024Yann MazabraudEVPSell1,594$51.38$81,899.72 2/9/2024Joseph ShulmanInsiderSell71,774$50.38$3,615,974.12 12/27/2023Joseph ShulmanInsiderSell5,015$50.01$250,800.15 12/5/2023Hunter C SmithCFOSell7,026$35.06$246,331.56 11/24/2023Hunter C SmithCFOSell10,974$35.02$384,309.48 11/8/2023Jennifer Kayden LeeEVPSell5,712$28.90$165,076.80 11/3/2023Jennifer Kayden LeeEVPSell80$28.00$2,240.00 9/5/2023Jennifer Kayden LeeEVPSell6,166$28.05$172,956.30 8/9/2023Jennifer Kayden LeeEVPSell1,718$24.66$42,365.88 8/7/2023Jennifer Kayden LeeEVPSell11,223$24.18$271,372.14 7/26/2023Pamela J CramerInsiderSell930$17.64$16,405.20 (Data available from 1/1/2013 forward) RYTM Insider Trading Activity - Frequently Asked Questions Who is on Rhythm Pharmaceuticals's Insider Roster? The list of insiders at Rhythm Pharmaceuticals includes Christopher Paul German, David P Meeker, Hunter C Smith, Jennifer Chien, Jennifer Kayden Lee, Joseph Shulman, Pamela J Cramer, William T Roberts, and Yann Mazabraud. Learn more on insiders at RYTM. What percentage of Rhythm Pharmaceuticals stock is owned by insiders? 5.60% of Rhythm Pharmaceuticals stock is owned by insiders. Learn more on RYTM's insider holdings. Which Rhythm Pharmaceuticals insiders have been selling company stock? The following insiders have sold RYTM shares in the last 24 months: Christopher Paul German ($15,367.68), David P Meeker ($1,784,274.68), Hunter C Smith ($1,358,789.18), Jennifer Chien ($50,033.17), Jennifer Kayden Lee ($654,011.12), Joseph Shulman ($5,686,134.23), Pamela J Cramer ($385,028.51), William T Roberts ($42,485.94), and Yann Mazabraud ($709,419.72). How much insider selling is happening at Rhythm Pharmaceuticals? Insiders have sold a total of 262,258 Rhythm Pharmaceuticals shares in the last 24 months for a total of $10,685,544.23 sold. More Insider Trading Tools from MarketBeat Related Companies: Pliant Therapeutics Insider Buying Annexon Insider Buying Theravance Biopharma Insider Buying Catalent Insider Buying Roivant Sciences Insider Buying Lantheus Insider Buying Revolution Medicines Insider Buying Summit Therapeutics Insider Buying Elanco Animal Health Insider Buying Krystal Biotech Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Selling: When It Matters and When It Doesn'tInsiders Sell These Tech Stocks, but Investors Shouldn’tWhat Does Market Rotation Mean for This Top AI Stock?3 Beaten Down Stocks That Insiders Are Buying3 Insider-Buy Stocks to Add to Your Watchlist Now This page (NASDAQ:RYTM) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.